Brind.

aTyr Pharma enrolled subjects at multiple centers globally, including Europe, for a clinical study.

2 reports, 1 independent Updated Thu 00:00

No new developments lately

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

aTyr Pharma enrolled subjects at multiple centers globally, including Europe, for a clinical study.

Who's involved

What this event is mainly about

aTyr Pharma Europe

Keep exploring

The entities involved

aTyr Pharma
company in San Diego, United States
- Cantor Fitzgerald reiterated an Overweight rating for aTyr Pharma on August 20, 2025.Sun 04:59
Europe
terrestrial continent located in north-western Eurasia
- The European Commission aims to strengthen homegrown AI capabilities while global advanced models face usage restrictions.Mon 17:49
- The European Central Bank is forced to raise interest rates due to energy price shocks from the Iran war and an influx of Chinese exports.Mon 17:49

Coverage

Newest first; wire copies grouped

Jul 22GlobeNewswireaTyr Pharma Announces Last Patient Visit in Phase 3 EFZO-FIT™ Study of Efzofitimod in Patients with Pulmonary Sarcoidosis Topline results expected in the third quarter of 2025. SAN DIEGO, July 22, 20

1 more outlet ran the same wire story

Thu 00:00manilatimes.net